Liposome and cholera toxin (CT) are considered to be effective antigen
delivery vehicles and adjuvants for mucosal vaccines. The effect of t
hese antigen delivery systems on adjuvant responses to mucosally admin
istered pneumococcal polysaccharide (Pnup) was investigated in this st
udy. Both mucosal (e.g oral) and systemic (IP) immunization of mice wi
th purified preparations of Pnup type 23F induced antigen-specific IgM
responses in sera. Interestingly, oral immunization of as little as 1
0 mu g of Pnup type 23P was sufficient to induce systemic IgM response
s, Pnup-specific IgM antibodies peaked by day 7 and no booster respons
es were evident after a second dose on day 14. In order to examine whe
ther IgG and IgA Pnup-specific immune responses are induced by mucosal
immunization, the mucosal adjuvant CT was mixed with Pnup type 23 as
an oral vaccine, Go-oral administration of CT and Pnup type 23F result
ed in the induction of Pnup-specific faecal IgA antibodies. These resu
lts were confirmed by defecting antigen-specific IgA-spot-forming cell
s in mononuclear cell suspensions prepared from the intestine of immun
ized mice. These findings suggest that oral immunization with Pnup in
the presence of mucosal adjuvants, such as CT, could induce Pnup-speci
fic IgA responses whereas Pnup alone did not. In an attempt to further
enhance antigen-specific antibody responses, Pnup type 23F was encaps
ulated in liposomes and used as mucosal vaccine. However, immunogenici
ty of Pnup was not improved. Copyright (C) 1996 Elsevier Science Ltd.